COPD稳定期α多样性分析：为何研究结果存在差异？2024最新证据解读

Alpha diversity is an important indicator reflecting the stability of the gut microbiome ecosystem. Compared to the control group, there were no statistically significant differences in the Chao1 index, Shannon index, Simpson index, and ACE index before intervention in the experimental group. This suggests that the species richness and diversity of the gut microbiota in patients with COPD in the stable phase with deficiency syndrome have not significantly decreased. During relatively stable disease phases, the overall number and evenness of gut microbial species can be maintained in a relatively steady state. A decrease in diversity is not the primary manifestation of microecological disorder in this syndrome type. Most previous studies have reported that COPD patients often exhibit a reduction in gut microbial diversity, with a smaller magnitude of change during the stable phase compared to the acute exacerbation phase, indicating that microecological disorders may primarily manifest as changes in species structure rather than a reduction in overall numbers. However, some studies have pointed out that the gut microbial diversity and richness in AECOPD patients are significantly reduced, while the microbial diversity in stable-phase COPD patients does not differ significantly from that of healthy controls. Systematic reviews and meta-analyses summarizing multiple studies have concluded that although some reports indicate a reduction in alpha diversity in COPD patients, meta-analysis results do not confirm a significant difference in alpha diversity between COPD patients and healthy controls. The changes in microbial diversity in stable-phase COPD patients are not significant and may be related to disease stage, severity, and medication use. In this study, all included patients were in the stable phase with deficiency syndrome, and those who had recently used antibiotics or probiotics were excluded, which may partially explain why no significant differences in diversity were observed. Additionally, the substantial heterogeneity of the gut microbiota among individuals may also mask inter-group differences. This is consistent with the conclusions of studies comparing the characteristics of gut microbiota in the stable and acute exacerbation phases of COPD.